NO20013179L - Aromatiske heterocyklusforbindelser som har HIV integrase- inhiberende aktiviteter - Google Patents

Aromatiske heterocyklusforbindelser som har HIV integrase- inhiberende aktiviteter

Info

Publication number
NO20013179L
NO20013179L NO20013179A NO20013179A NO20013179L NO 20013179 L NO20013179 L NO 20013179L NO 20013179 A NO20013179 A NO 20013179A NO 20013179 A NO20013179 A NO 20013179A NO 20013179 L NO20013179 L NO 20013179L
Authority
NO
Norway
Prior art keywords
aromatic heterocycle
hiv integrase
inhibitory activities
heterocycle compounds
integrase inhibitory
Prior art date
Application number
NO20013179A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013179D0 (no
Inventor
Toshio Fujishita
Tomokazu Yoshinaga
Akihiko Sato
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of NO20013179D0 publication Critical patent/NO20013179D0/no
Publication of NO20013179L publication Critical patent/NO20013179L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/34Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20013179A 1998-12-25 2001-06-22 Aromatiske heterocyklusforbindelser som har HIV integrase- inhiberende aktiviteter NO20013179L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP37127098 1998-12-25
JP24747999 1999-09-01
PCT/JP1999/007101 WO2000039086A1 (fr) 1998-12-25 1999-12-17 Composes heterocycliques aromatiques possedant des activites inhibitrices de l'integrase du vih

Publications (2)

Publication Number Publication Date
NO20013179D0 NO20013179D0 (no) 2001-06-22
NO20013179L true NO20013179L (no) 2001-08-27

Family

ID=26538287

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013179A NO20013179L (no) 1998-12-25 2001-06-22 Aromatiske heterocyklusforbindelser som har HIV integrase- inhiberende aktiviteter

Country Status (22)

Country Link
US (3) US6620841B1 (zh)
EP (1) EP1142872B1 (zh)
JP (1) JP3929244B2 (zh)
KR (1) KR20010089708A (zh)
CN (1) CN1178913C (zh)
AP (1) AP2001002169A0 (zh)
AT (1) ATE411286T1 (zh)
AU (1) AU763040B2 (zh)
BR (1) BR9916583A (zh)
CA (1) CA2353961A1 (zh)
CZ (1) CZ20012160A3 (zh)
DE (1) DE69939749D1 (zh)
HK (1) HK1042701A1 (zh)
HU (1) HUP0201472A3 (zh)
ID (1) ID29027A (zh)
IL (1) IL143958A0 (zh)
NO (1) NO20013179L (zh)
NZ (1) NZ512184A (zh)
PL (1) PL348596A1 (zh)
RU (1) RU2225860C2 (zh)
TR (1) TR200101886T2 (zh)
WO (1) WO2000039086A1 (zh)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6380249B1 (en) 1998-06-03 2002-04-30 Merck & Co., Inc. HIV integrase inhibitors
US6306891B1 (en) 1998-06-03 2001-10-23 Merck & Co., Inc. HIV integrase inhibitors
US6262055B1 (en) 1998-06-03 2001-07-17 Merck & Co., Inc. HIV integrase inhibitors
DE69925918T2 (de) 1998-07-27 2006-05-11 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Diketosäure-derivate als hemmstoffe von polymerasen
GB9816358D0 (en) 1998-07-27 1998-09-23 Angeletti P Ist Richerche Bio Enzyme inhibitors
CN1367784A (zh) * 1999-06-02 2002-09-04 盐野义制药株式会社 新的取代丙烯酮衍生物的制备方法
EP1196384A4 (en) * 1999-06-25 2002-10-23 Merck & Co Inc 1- (AROMATIC OR HETEROAROMATICALLY SUBSTITUTED) -3- (HETEROAROMATICALLY SUBSTITUTED) -1,3-PROPANDIONS AND THEIR APPLICATIONS
CA2410763A1 (en) * 2000-06-13 2002-11-28 Shionogi & Co., Ltd. Medicinal compositions containing propenone derivatives
AU2001262732A1 (en) * 2000-06-14 2001-12-24 Shionogi And Co., Ltd. Inhibitor for enzyme having two divalent metal ions as active centers
AU2002212701A1 (en) * 2000-11-09 2002-05-21 Shionogi And Co., Ltd. Drug-tolerant hiv integrases
KR20100087209A (ko) 2001-08-10 2010-08-03 시오노기세이야쿠가부시키가이샤 항바이러스제
RS51542B (sr) * 2001-10-26 2011-06-30 Istituto Di Ricerche Di Biologia Molecolare P.Angeletti Spa. N-supstituisani hidroksipirimidinon karboksamidni inhibitori hiv integraze
TW200407132A (en) * 2001-11-15 2004-05-16 Shionogi & Co Process for producing 1-H-1,2,4-triazole-3-carboxylic acid ester
JP4497347B2 (ja) * 2001-12-05 2010-07-07 塩野義製薬株式会社 Hivインテグラーゼ阻害活性を有する誘導体
WO2004024693A1 (ja) 2002-08-13 2004-03-25 Shionogi & Co., Ltd. Hivインテグラーゼ阻害活性を有するヘテロ環化合物
WO2004035577A2 (en) 2002-10-16 2004-04-29 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
CN1569803B (zh) * 2003-07-16 2011-04-13 中国科学院上海药物研究所 芳基β-二酮酸的新制备方法
AU2005208938A1 (en) * 2004-01-29 2005-08-11 Elixir Pharmaceuticals, Inc Anti-viral therapeutics
IN2014CN03762A (zh) * 2004-08-25 2015-09-25 Ardea Biosciences Inc
EP1790638B1 (en) * 2004-09-15 2013-04-03 Shionogi Co., Ltd. Carbamoylpyridone derivative having hiv integrase inhibitory activity
EP1819323B2 (en) * 2004-12-03 2023-03-22 Merck Sharp & Dohme Corp. Pharmaceutical composition containing an anti-nucleating agent
UA87884C2 (uk) * 2004-12-03 2009-08-25 Мерк Энд Ко., Инк. Безводна кристалічна калієва сіль інгібітора віл-інтегрази
US7250421B2 (en) * 2005-01-31 2007-07-31 University Of Georgia Research Foundation, Inc. Diketo acids with nucleobase scaffolds: anti-HIV replication inhibitors targeted at HIV integrase
US20080280849A1 (en) * 2005-06-01 2008-11-13 Herve Leh Synergic Combinations Comprising a Quinoline Compound and Other Hiv Infection Therapeutic Agents
WO2007136714A2 (en) * 2006-05-16 2007-11-29 Gilead Sciences, Inc. Integrase inhibitors
EP2046328A4 (en) * 2006-07-19 2009-10-28 Univ Georgia Res Found PYRIDINONE DIKETOIC ACIDS: INHIBITORS OF HIV REPLICATION IN COMBINATION THERAPY
WO2008041882A1 (fr) * 2006-10-03 2008-04-10 Viktor Veniaminovich Tets Procédé pour agir sur les virus au moyen d'une substance à base de 2,8-dithioxo-1h- pyrano[2,3-d;6,5-d'] dipyrimidine et de leurs analogues 10-aza (et variantes)
CN102670628B (zh) 2008-01-25 2015-11-25 奇默里克斯公司 治疗病毒感染的方法
US8664255B2 (en) 2008-10-20 2014-03-04 The Texas A&M University System Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof
AU2010328325B2 (en) 2009-12-07 2015-02-05 University Of Georgia Research Foundation, Inc. Pyridinone hydroxycyclopentyl carboxamides: HIV integrase inhibitors with therapeutic applications
DK2534150T3 (en) 2010-02-12 2017-06-12 Chimerix Inc METHODS OF TREATING VIRUS INFECTION
EP2550362B1 (en) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
CN101928258B (zh) * 2010-08-18 2014-10-29 杭州民生药业有限公司 1-(2-取代苯胺基-4-甲基-噻唑-5)-3-取代苯基-丙烯酮衍生物、制备方法及其制药用途
PT2691530T (pt) 2011-06-10 2018-05-10 Univ Oregon Health & Science Glicoproteínas e vectores recombinantes cmv
WO2014026033A1 (en) * 2012-08-08 2014-02-13 University Of Florida Research Foundation, Inc. Cross-reactive t cell epitopes of hiv, siv, and fiv for vaccines in humans and cats
MD4736C1 (ro) 2012-12-21 2021-07-31 Gilead Sciences, Inc. Compus policiclic de carbamoilpiridonă şi utilizarea farmaceutică a acestuia
HUE037347T2 (hu) 2013-07-12 2018-08-28 Gilead Sciences Inc Policiklusos karmaboilpiridon vegyületek és alkalmazásuk HIV fertõzések kezelésére
NO2865735T3 (zh) 2013-07-12 2018-07-21
TWI677489B (zh) 2014-06-20 2019-11-21 美商基利科學股份有限公司 多環型胺甲醯基吡啶酮化合物之合成
NO2717902T3 (zh) 2014-06-20 2018-06-23
TW201613936A (en) 2014-06-20 2016-04-16 Gilead Sciences Inc Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
TWI695003B (zh) 2014-12-23 2020-06-01 美商基利科學股份有限公司 多環胺甲醯基吡啶酮化合物及其醫藥用途
PL3277691T3 (pl) 2015-04-02 2019-07-31 Gilead Sciences, Inc. Policykliczne związki karbamoilopirydonowe i ich zastosowanie farmaceutyczne
CN106905244B (zh) * 2017-02-27 2019-08-16 武汉工程大学 二芳基嘧啶-二酮酸类杂合型hiv-1抑制剂及其制备方法
BR112022008074A2 (pt) * 2019-10-28 2022-07-12 Shanghai Inst Materia Medica Cas Composto de ácido oxocarboxílico heterocíclico de cinco membros e uso médico do mesmo
CN111943899B (zh) * 2020-09-08 2023-04-21 河北凯诺中星科技有限公司 一种5-甲酸乙酯四氮唑的合成方法
CN113683574B (zh) * 2021-09-06 2023-11-17 上海晋鲁医药科技有限公司 一种合成1-甲基-1h-1,2,4-三唑-3-甲酸甲酯的方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899508A (en) 1974-04-12 1975-08-12 Lilly Co Eli 5-(2-Aminophenyl)pyrazole-3-carboxylic acids and esters thereof
US3931247A (en) 1974-12-11 1976-01-06 Morton-Norwich Products, Inc. 5-(Substituted)phenylfurfuryl alcohols
JPS5811878B2 (ja) 1974-12-19 1983-03-04 大正製薬株式会社 フロ ( 3 2−b ) インド−ルルイノ セイホウ
JPS56100784A (en) 1980-01-16 1981-08-12 Yoshitomi Pharmaceut Ind Ltd Indolizine derivative
US4273776A (en) 1980-01-30 1981-06-16 E. R. Squibb & Sons, Inc. Antibacterial and antifungal derivatives of 3-(1H-imidazol-1-yl)-2-propen-1-ones
US4423063A (en) 1980-12-29 1983-12-27 Merck & Co., Inc. 2,4-Dioxo-4-substituted-1-butaoic acid derivatives useful in treating urinary track calcium oxalate lithiasis
US4336397A (en) 1980-12-29 1982-06-22 Merck & Co., Inc. 2,4-Dioxo-4-substituted-1-butanoic acid derivatives useful in treating urinary tract calcium oxalate lithiasis
US4332735A (en) 1981-07-06 1982-06-01 Morton-Norwich Products, Inc. Antifungal compound
US4637829A (en) 1984-04-27 1987-01-20 Ciba-Geigy Corporation Sulfonylureas
JPS61134346A (ja) 1984-12-03 1986-06-21 Shionogi & Co Ltd 4−オキソカルボン酸誘導体および抗潰瘍剤
CA1334975C (en) * 1987-11-13 1995-03-28 James H. Holms Furan and pyrrole containing lipoxygenase inhibiting compounds
JPH0238403A (ja) 1988-07-28 1990-02-07 Canon Inc 光重合性組成物および記録媒体
PH27357A (en) 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
US5192773A (en) * 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
TW224974B (zh) * 1991-07-02 1994-06-11 Hoffmann La Roche
EP0658559A1 (de) * 1993-12-14 1995-06-21 Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren
US5475109A (en) 1994-10-17 1995-12-12 Merck & Co., Inc. Dioxobutanoic acid derivatives as inhibitors of influenza endonuclease
US5693804A (en) * 1994-11-17 1997-12-02 Molecular Geriatrics Corporation Substituted 1-aryl-3-piperazin-1'-yl propanones
NZ337698A (en) 1997-04-04 2001-07-27 Pfizer Prod Inc Nicotinamide derivatives for selective inhibition of phosphodiesterase type 4 (PDE4) and the production of tumour necrosis factor (TNF) useful for the treatment of respiratory, rheumatoid and allergic diseases
IL122591A0 (en) 1997-12-14 1998-06-15 Arad Dorit Pharmaceutical compositions comprising cystein protease inhibitors
CN1142909C (zh) 1998-03-26 2004-03-24 盐野义制药株式会社 具有抗病毒活性的吲哚衍生物
AU3366899A (en) 1998-03-27 1999-10-18 Regents Of The University Of California, The Novel hiv integrase inhibitors and hiv therapy based on drug combinations including integrase inhibitors
JP2002516858A (ja) 1998-06-03 2002-06-11 メルク エンド カムパニー インコーポレーテッド Hivインテグラーゼ阻害薬
AU757409B2 (en) 1998-06-03 2003-02-20 Merck & Co., Inc. Hiv integrase inhibitors
EP1082121A4 (en) * 1998-06-03 2003-02-05 Merck & Co Inc INTEGRASE HIV INHIBITORS
EP1196384A4 (en) 1999-06-25 2002-10-23 Merck & Co Inc 1- (AROMATIC OR HETEROAROMATICALLY SUBSTITUTED) -3- (HETEROAROMATICALLY SUBSTITUTED) -1,3-PROPANDIONS AND THEIR APPLICATIONS

Also Published As

Publication number Publication date
RU2225860C2 (ru) 2004-03-20
HUP0201472A2 (hu) 2003-10-28
CN1335834A (zh) 2002-02-13
BR9916583A (pt) 2001-09-25
RU2001120016A (ru) 2003-12-10
ID29027A (id) 2001-07-26
AU763040B2 (en) 2003-07-10
WO2000039086A1 (fr) 2000-07-06
US6645956B1 (en) 2003-11-11
EP1142872A1 (en) 2001-10-10
CN1178913C (zh) 2004-12-08
DE69939749D1 (de) 2008-11-27
EP1142872B1 (en) 2008-10-15
US7098201B2 (en) 2006-08-29
ATE411286T1 (de) 2008-10-15
EP1142872A4 (en) 2002-04-17
US6620841B1 (en) 2003-09-16
HK1042701A1 (zh) 2002-08-23
NO20013179D0 (no) 2001-06-22
US20040002485A1 (en) 2004-01-01
HUP0201472A3 (en) 2006-03-28
AP2001002169A0 (en) 2001-06-30
CA2353961A1 (en) 2000-07-06
JP3929244B2 (ja) 2007-06-13
NZ512184A (en) 2003-08-29
IL143958A0 (en) 2002-04-21
TR200101886T2 (tr) 2001-12-21
CZ20012160A3 (cs) 2001-10-17
PL348596A1 (en) 2002-06-03
AU1797900A (en) 2000-07-31
KR20010089708A (ko) 2001-10-08

Similar Documents

Publication Publication Date Title
NO20013179L (no) Aromatiske heterocyklusforbindelser som har HIV integrase- inhiberende aktiviteter
NO20042673L (no) Acetylenderivaer som har mGluR5 antagonistisk aktivitet
DK1104420T3 (da) Substituerede 1,8-naphthyridin-4(1H)-oner som phosphodiesterase-4-inhibitorer
AU2003257822A1 (en) Heterocyclic compound having hiv integrase inhibitory activity
DK0882024T3 (da) Forbindelser, som inhiberer retroviral protease
DK1222192T3 (da) Hexahydrofuro-2,3-b furan-3-yl-N-3-(1,3-benzodioxol-5-ylsulfonyl)(isobutyl)amino-1-benzyl-2-hydroxypropyl-carbamat som retroviral proteaseinhibitor
NO20030153L (no) Blandinger som inneholder terapeutisk aktive komponenter som har foröket löselighet
BR9915552B1 (pt) Pirimidinas inibidoras da reprodução do hiv
DK0945443T3 (da) HIV-hæmmende pyrimidinderivater
DK0920421T3 (da) Isoxazolinderivater anvendelige som antimikrobielle midler
AU2001295310A1 (en) Aromatic derivatives with hiv integrase inhibitory properties
NO20032926D0 (no) Heterocykliske forbindelser som har antibakteriell aktivitet, fremgangsmåtefor deres fremstilling og farmasöytiske sammensetningerinneholdende dem
NO20022557D0 (no) 2,4-diaminopyrimidinforbindelser nyttige som immunosuppreserende midler
DE69906981D1 (de) Herbizide phenoxypropionsäure-n-alkyl-n-2-fluorophenylamid-verbindungen
NO20030100D0 (no) Pleuromutilinderivater som har antibakteriell aktivitet
NO20025635L (no) Anvendelse av biguanidderivater til fremstilling av et legemiddel som har en sarhelende virkning
AU2002349675A1 (en) Derivative having hiv integrase inhibitory activity
NO20032614L (no) Farmasöytisk sammensetning som har forbedret absorberbarhet
DE50006096D1 (de) Herbizide mittel
DE60002655D1 (de) Modularer helm
NO972914L (no) Substituerte tiadiazoler, blandinger inneholdende dem og deres anvendelse som antimikrobielle og marine antibegroingsmidler
IT1308147B1 (it) Elemento attivo per tamburi fresanti dimacchine operatrici per la rimozione di suoli, provvisto di
PT1192154E (pt) Compostos de bispidina uteis para o tratamento de arritmias cardiacas
FI991043A0 (fi) Antennijärjestely, jolla on kaksi toimintataajuusaluetta
DK1192156T3 (da) Bispidinforbindelser, som er egnede til behandling af hjertearytmier

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application